WNT3A and central nervous system cancer: To study whether CELSR2 serves as a potential receptor of WNT ligands to impact the development of glioma cells, WNT3A, WNT5A and WNT1 were administered to cultured U87 MG cells transfected without or with CELSR2-shRNA (CELSR2 KD).